New York State Common Retirement Fund’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

New York State Common Retirement Fund’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-55,855	Closed	-$7.37M	–	3390
2025 Q1	$7.37M	Sell	55,855 -20,708	-27%	-$2.58M	0.01%	852
2024 Q4	$6.39M	Buy	76,563 +5,162	+7%	+$424K	0.01%	997
2024 Q3	$5.22M	Sell	71,401 -14,805	-17%	-$1.11M	0.01%	1081
2024 Q2	$5.9M	Buy	86,206 +28,050	+48%	+$1.95M	0.01%	1049
2024 Q1	$4.02M	Buy	58,156 +584	+1%	+$40.1K	0.01%	1201
2023 Q4	$4.12M	Buy	57,572 +5,023	+10%	+$289K	0.01%	1186
2023 Q3	$2.74M	Sell	52,549 -45,461	-46%	-$2.65M	﹤0.01%	1326
2023 Q2	$6.21M	Buy	98,010 +17,757	+22%	+$1.11M	0.01%	1074
2023 Q1	$4.35M	Sell	80,253 -56,562	-41%	-$2.73M	0.01%	1237
2022 Q4	$7.24M	Buy	136,815 +11,581	+9%	+$580K	0.01%	1022
2022 Q3	$5.83M	Sell	125,234 -56,977	-31%	-$2.98M	0.01%	1084
2022 Q2	$10.4M	Buy	182,211 +8,098	+5%	+$459K	0.01%	858
2022 Q1	$10.7M	Buy	174,113 +69,845	+67%	+$3.63M	0.01%	932
2021 Q4	$5.46M	Sell	104,268 -112	-0.1%	-$4.71K	0.01%	1259
2021 Q3	$3.89M	Buy	104,380 +11,521	+12%	+$401K	﹤0.01%	1423
2021 Q2	$3.79M	Buy	92,859 +14,066	+18%	+$520K	﹤0.01%	1479
2021 Q1	$2.67M	Sell	78,793 -587	-0.7%	-$20.4K	﹤0.01%	1604
2020 Q4	$2.52M	Buy	79,380 +5,970	+8%	+$157K	﹤0.01%	1579
2020 Q3	$1.88M	Buy	73,410 +21,810	+42%	+$498K	﹤0.01%	1605
2020 Q2	$1.32M	Buy	51,600 +10,400	+25%	+$211K	﹤0.01%	1727
2020 Q1	$633K	Hold	41,200	–	–	﹤0.01%	1938
2019 Q4	$1.41M	Sell	41,200 -2,700	-6%	-$32.4K	﹤0.01%	1785
2019 Q3	$328K	Hold	43,900	–	–	﹤0.01%	2532
2019 Q2	$570K	Hold	43,900	–	–	﹤0.01%	2309
2019 Q1	$535K	Hold	43,900	–	–	﹤0.01%	2275
2018 Q4	$500K	Sell	43,900 -7,300	-14%	-$118K	﹤0.01%	2282
2018 Q3	$1.11M	Hold	51,200	–	–	﹤0.01%	2029
2018 Q2	$905K	Buy	51,200 +5,500	+12%	+$112K	﹤0.01%	2152
2018 Q1	$962K	Buy	45,700 +10,000	+28%	+$195K	﹤0.01%	2045
2017 Q4	$517K	Hold	35,700	–	–	﹤0.01%	2340
2017 Q3	$563K	Hold	35,700	–	–	﹤0.01%	2298
2017 Q2	$443K	Sell	35,700 -1	-0%	-$12	﹤0.01%	2463
2017 Q1	$580K	Buy	35,701 +1	+0%	+$14	﹤0.01%	2321
2016 Q4	$539K	Sell	35,700 -2,644	-7%	-$37.3K	﹤0.01%	2341
2016 Q3	$584K	Buy	38,344 +8,893	+30%	+$360K	﹤0.01%	2240
2016 Q2	$1.14M	Sell	29,451 -14,708	-33%	-$528K	﹤0.01%	1900
2016 Q1	$1.23M	Buy	44,159 +17,559	+66%	+$585K	﹤0.01%	1837
2015 Q4	$1.43M	Buy	26,600 +5,800	+28%	+$293K	﹤0.01%	1780
2015 Q3	$833K	Sell	20,800 -1,333	-6%	-$43.5K	﹤0.01%	2053
2015 Q2	$707K	Buy	+22,133	New	+$561K	﹤0.01%	2366

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York State Common Retirement Fund's ITCI Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 55,855 shares — an estimated $7.37M sold.

New York State Common Retirement Fund first reported a position in ITCI in Q2 2015 and held it in 40 quarters. The position peaked at $10.7M in Q1 2022. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

New York State Common Retirement Fund reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
New York State Common Retirement Fund sold 55,855 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $7.37M.
New York State Common Retirement Fund first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 40 quarters.
New York State Common Retirement Fund's Intra-Cellular Therapies Inc. position peaked at $10.7M in Q1 2022.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.